| Income Statement |
| Operating Expenses | 6.63M |
|
| Research and Development Expense | 1.24M |
| Selling, General and Administrative Expense | 5.40M |
| Operating Income | -6.63M |
| Net Income | -7.11M |
| Net Income Common Stock | -7.11M |
| Net Income Common Stock (USD) | -7.11M |
| Consolidated Income | -7.11M |
| Earnings per Basic Share | -0.06 |
| Earnings per Basic Share (USD) | -0.06 |
| Earnings per Diluted Share | -0.06 |
| Earning Before Interest & Taxes (EBIT) | -7.11M |
| Earning Before Interest & Taxes (USD) | -7.11M |
| Weighted Average Shares | 110.23M |
| Weighted Average Shares Diluted | 110.23M |
| Balance Sheet |
| Cash and Equivalents | 96.70M |
| Cash and Equivalents (USD) | 96.70M |
| Current Assets | 101.48M |
| Property, Plant & Equipment Net | 417.00K |
| Total Assets | 101.90M |
| Current Liabilities | 4.76M |
| Total Liabilities | 200.59M |
| Accumulated Retained Earnings (Deficit) | -614.38M |
| Accumulated Other Comprehensive Income | -8.10M |
| Shareholders Equity | -98.69M |
| Shareholders Equity (USD) | -98.69M |
| Assets Non-Current | 417.00K |
| Liabilities Non-Current | 195.84M |
| Trade and Non-Trade Payables | 737.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 6.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.18M |
| Capital Expenditure | -328.00K |
| Net Cash Flow from Investing | -328.00K |
| Net Cash Flow from Operations | -3.86M |
| Effect of Exchange Rate Changes on Cash | -2.00M |